dry extract of emblica officinalis
UkraineDrugs containing this active substance
-
The drug is used for the symptomatic treatment of acute and chronic diseases of the upper respiratory tract accompanied by coughing (e.g., pharyngitis, laryngitis, tracheitis, bronchitis).
Form: lozenges
Active substance Dosage dry extract of glycyrrhiza glabra 3.0 mg dry extract of ginger root 1.0 mg dry extract of emblica officinalis 2.5 mg menthol 7.0 mg ATC: R05X
Manufacturer: Unik Pharmaceuticals Laboratories (branch of the company "J. B. Chemicals and Pharmaceuticals Ltd.")
-
The drug is used for the symptomatic treatment of acute and chronic diseases of the upper respiratory tract accompanied by coughing (e.g., pharyngitis, laryngitis, tracheitis, bronchitis).
Form: lozenges
Active substance Dosage dry extract of glycyrrhiza glabra 3.0 mg dry extract of ginger root 1.0 mg dry extract of emblica officinalis 2.5 mg menthol 7.0 mg ATC: R05X
Manufacturer: Unik Pharmaceuticals Laboratories (branch of the company "J. B. Chemicals and Pharmaceuticals Ltd.")
-
The drug is used for the symptomatic treatment of acute and chronic diseases of the upper respiratory tract accompanied by coughing (e.g., pharyngitis, laryngitis, tracheitis, bronchitis).
Form: lozenges
Active substance Dosage dry extract of glycyrrhiza glabra 3.0 mg dry extract of ginger root 1.0 mg dry extract of emblica officinalis 2.5 mg menthol 7.0 mg ATC: R05X
Manufacturer: Unik Pharmaceuticals Laboratories (branch of the company "J. B. Chemicals and Pharmaceuticals Ltd.")
-
The drug is used to relieve symptoms of acute and chronic upper respiratory tract diseases accompanied by coughing, such as pharyngitis, laryngitis, tracheitis, and bronchitis.
Form: lozenges
Active substance Dosage dry extract of glycyrrhiza glabra 3.0 mg dry extract of ginger root 1.0 mg dry extract of emblica officinalis 2.5 mg menthol 7.0 mg ATC: R05X
Manufacturer: Unik Pharmaceuticals Laboratories (branch of the company "J. B. Chemicals and Pharmaceuticals Ltd.")